Stem cell treatments can address the challenges in disease progression by offering the most noninvasive treatment available to limit the cells damage and reduce the symptoms. The stem cells are capable of differentiation in various cell lines and can work in synchrony with tissue specific cells for regeneration and recovery.
These cells are administered through one of two methods after a considerable analysis of the patient’s unique history.
Intrathecal Administration
In this mode, cells are infused in the cerebrospinal fluid through subarachnoid spaces of the spinal cord.
Intravenous Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
These infused cells reach the site and through paracrine effects they then differentiate into neurons and help revive the damaged ones to restore proper function. Thus, with stem cell-based therapies it is now possible to obtain noticeable improvements and arrest progression in patients with Multiple Sclerosis.